---
title: "Trulieve Cannabis Corp. (TCNNF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TCNNF.US.md"
symbol: "TCNNF.US"
name: "Trulieve Cannabis Corp."
industry: "Pharmaceuticals"
datetime: "2026-05-19T17:16:40.050Z"
locales:
  - [en](https://longbridge.com/en/quote/TCNNF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TCNNF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TCNNF.US.md)
---

# Trulieve Cannabis Corp. (TCNNF.US)

## Company Overview

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.trulieve.com](https://www.trulieve.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:13.000Z

**Overall: D (0.64)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 130 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.39% |  |
| Net Profit YoY | 50.81% |  |
| P/B Ratio | 1.31 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1532696481.74 |  |
| Revenue | 1170174000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -6.34% | D |
| Profit Margin | -6.93% | D |
| Gross Margin | 59.31% | B |
| Revenue YoY | -1.39% | D |
| Net Profit YoY | 50.81% | B |
| Total Assets YoY | -3.66% | D |
| Net Assets YoY | -5.71% | D |
| Cash Flow Margin | -342.02% | E |
| OCF YoY | -1.39% | D |
| Turnover | 0.41 | C |
| Gearing Ratio | 58.69% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Trulieve Cannabis Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.39%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "50.81%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.31",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1532696481.74",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1170174000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-6.34%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-6.93%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "59.31%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.39%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "50.81%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-3.66%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-5.71%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-342.02%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-1.39%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.41",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "58.69%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -18.90 | 207/190 | - | - | - |
| PB | 1.31 | 66/190 | 1.35 | 1.10 | 0.83 |
| PS (TTM) | 1.31 | 36/190 | 1.37 | 1.12 | 0.85 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-08T04:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 6 | 86% |
| Overweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.74 |
| Highest Target | 21.00 |
| Lowest Target | 21.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TCNNF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TCNNF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TCNNF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TCNNF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**